A prospective observational cohort study to identify inflammatory biomarkers for the diagnosis and prognosis of patients with sepsis

Abstract

Background Sepsis is a life-threatening organ dysfunction. A fast diagnosis is crucial for patient management. Proteins that are synthesized during the inflammatory response can be used as biomarkers, helping in a rapid clinical assessment or an early diagnosis of infection. The aim of this study was to identify biomarkers of inflammation for the diagnosis and prognosis of infection in patients with suspected sepsis. Methods In total 406 episodes were included in a prospective cohort study. Plasma was collected from all patients with suspected sepsis, for whom blood cultures were drawn, in the emergency department (ED), the department of infectious diseases, or the haemodialysis unit on the first day of a new episode. Samples were analysed using a 92-plex proteomic panel based on a proximity extension assay with oligonucleotide-labelled antibody probe pairs (OLink, Uppsala, Sweden). Supervised and unsupervised differential expression analyses and pathway enrichment analyses were performed to search for inflammatory proteins that were different between patients with viral or bacterial sepsis and between patients with worse or less severe outcome. Results Supervised differential expression analysis revealed 21 proteins that were significantly lower in circulation of patients with viral infections compared to patients with bacterial infections. More strongly, higher expression levels were observed for 38 proteins in patients with high SOFA scores (> 4), and for 21 proteins in patients with worse outcome. These proteins are mostly involved in pathways known to be activated early in the inflammatory response. Unsupervised, hierarchical clustering confirmed that inflammatory response was more strongly related to disease severity than to aetiology. Conclusion Several differentially expressed inflammatory proteins were identified that could be used as biomarkers for sepsis. These proteins are mostly related to disease severity. Within the setting of an emergency department, they could be used for outcome prediction, patient monitoring, and directing diagnostics. Trail registration number: clinicaltrial.gov identifier NCT03841162.

A cytokine/PTX3 prognostic index as a predictor of mortality in sepsis

“…The role of the immune system in sepsis is generally recognized and involves multiple processes, ranging from activation of pro-inflammatory mechanisms to immunosuppression, often occurring simultaneously ( 87 – 89 ). Early activation of the inflammatory response is involved in the pathogenesis of sepsis, and the altered levels of several cytokines observed in septic patients compared to healthy controls are likely involved in the organ injury observed in sepsis ( 9 , 90 ). In our cohort of patients, we observed significant changes in the levels of the panel of pro-inflammatory (IL-1β, IL-6, IL-8, IL-18, TNF-α) and anti-inflammatory (IL-10, IL-1ra) cytokines.…”

Performance effectiveness of vital parameter combinations for early warning of sepsis—an exhaustive study using machine learning

“…Such infectious diseases put intensive care unit (ICU) patients at increased risk of unnoticed progression to sepsis, ultimately leading to avoidable increases in morbidity and mortality. 1 , 2…”

Identification of biomarkers and therapeutic targets related to Sepsis-associated encephalopathy in rats by quantitative proteomics

“…Several studies have reported the proteomic changes in plasma, urine, liver, heart, etc. of both septic patients and animal models [ 6 – 8 ]. However, little research has focused on the proteins changing in the brain tissue of sepsis models.…”